Through
5/7
It’s long been known that someone’s previous choices subconsciously affect those they make in the future. New research could pave the way for a deeper investigation into how such thought processes work.
Michele W. Berger ・
Findings from a study of male rhesus macaques from PIK professor Michael Platt and postdoc Yaoguang Jiang could lead to treatment options for social impairments in disorders like autism and schizophrenia.
Michele W. Berger ・
In a quest to ease the care process for older adults and the very sick, as well as their family-member caregivers, PIK professor George Demiris is studying the intersection of smart-home technologies and health informatics.
Michele W. Berger ・
When St. Joseph Aspirin for Children was introduced in the 1940s, it was formulated to be attractive in taste and color to its young audience. Dubbed “candy aspirin,” the product became popular—fast. As a consequence, aspirin poisonings of children under five skyrocketed.
Michele W. Berger ・
A new “match” for clinical psychology graduate students connects trainees with potential externship sites. In its second year, the initiative successfully matched more than 250 trainees in the mid-Atlantic region.
Michele W. Berger ・
For capital crimes like rape and murder, wrongful convictions happen in about 3 to 5 percent of cases. Such an estimate had proved elusive for the prison population as a whole—until now, thanks to work from Penn criminologists.
Michele W. Berger ・
Driverless trucks seem like science fiction, part of a far-off world where robots and humans live and work side by side.
Michele W. Berger ・
New research out of the philosophy department argues that certain racial classifications have utility in medical genetics, particularly when considering those classifications as ancestry groups.
Michele W. Berger ・
New research led by Annenberg’s Joseph Turow reveals that political party and orientation matter when it comes to how Americans feel about everyday surveillance of low-income populations.
Michele W. Berger ・
New research revealed that FDA-approved drugs to treat diabetes and obesity may reduce cocaine relapse and help addicts break the habit. Such medications work by targeting receptors for glucagon-like peptide 1, a hormone in the brain.
Michele W. Berger ・